Connect Biopharma Holdings Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Connect Biopharma Holdings Ltd and you wish to licence your Sustainability aseessment, please contact us. This page contains a zero-cost Environmental, Social and Governance report covering Connect Biopharma Holdings Ltd. This webpage contains a Q&A table on Connect Biopharma Holdings Ltd.
Connect Biopharma Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 2.0, social score of 6.4 and governance score of 4.8.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 868 | Trevena Inc | 4.5 | High |
| 868 | Urogen Pharma Ltd | 4.5 | High |
| 910 | Connect Biopharma Holdings Ltd | 4.4 | High |
| 910 | CanBas Co Ltd | 4.4 | High |
| 910 | CNS Pharmaceuticals Inc | 4.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Connect Biopharma Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd report the average age of the workforce?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd offer flexible work?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd conduct supply chain audits?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose water use targets?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Connect Biopharma Holdings Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Connect Biopharma Holdings Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Connect Biopharma Holdings Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose its waste policy?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose energy use targets?
Sign up for free to unlockDoes Connect Biopharma Holdings Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Connect Biopharma Holdings Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Connect Biopharma Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.